One in 285 children in the U.S. will be diagnosed with cancer by the time they are 20 years old.
WE FIGHT FOR THE
We have lots of hope. Discovery is the enemy of pediatric cancer, and Hyundai Hope On Wheels funds discovery – awarding major grants to research centers actively investigating treatments and cures. By the end of 2017, $145 million will have been awarded to groundbreaking research institutes across the country.
Every time a Hyundai vehicle is purchased, Hyundai and its U.S. dealers make a donation to Hyundai Hope On Wheels.
Meet Our New Ambassadors.
Meet Carter and Elizabeth, our 2018-2019 National Youth Ambassadors. Every two years, Hope On Wheels selects two brave pediatric cancer survivors to represent the program as National Youth Ambassadors. Carter and Elizabeth will join Hope On Wheels in our mission to fight childhood cancer and will travel around the US visiting children’s hospitals and attending events to tell their stories of courage and hope.
The Children Give Us All Hope
Each day, 43 families in the United States find out that their child has cancer. Cancer’s impact on children can be devastating, but there is reason for hope. Now, thankfully more than 80% of children with cancer survive. And, with our support, member institutions of the Children’s Oncology Groups of America are working toward the day when no child ever dies from pediatric cancer. Children deserve to grow, learn and play in a world free of this disease. These are their stories of hope.
“Cancer made me stronger.
I had cancer, but cancer never had me.”
HEROES OF HOPE
Click icon to watch video
How We Create Hope.
Hyundai Hope On Wheels is one of the largest private funders of research into pediatric cancer. Hyundai Hope On Wheels awards financial support – in specific fields of research – to Children’s Oncology Group member institutions. Our mission is to find a cure for childhood cancer one handprint at a time. This highly-regarded program seeks to expand the knowledge base for pediatric cancer – and to improve the standards of care. In 2017 alone, Hyundai Hope On Wheels presented more than $15 million in research grants across the United States. Grants can range from $50 thousand to $1 million, and more.
Novel combination therapy using CK2 inhibitor in high risk pediatric Leukemia.
Wheel of Hope
to advancing treatment for high-risk
forms of childhood cancer.
researchers involved with
translational research, working
directly with patients.
for principal investigators
researching the biology
of childhood cancer.
for innovative research in
the childhood cancer field.
+ Hyundai Quantum Grants $1M – $2.5M
This grant is dedicated to advancing treatment for high-risk forms of childhood cancer.
+ Hyundai Hope Scholar Grants $300K
This grant is presented to researchers involved with translational research, working directly with patients.
+ Hyundai Young Investigator Grants $200K
This grant provides funding for principal investigators researching the biology of childhood cancer.
+ Hyundai Impact Grants $100K
This grant provides funding for innovative research in the childhood cancer field.
HYUNDAI HOPE ON WHEELS HAS AWARDED MORE THAN
$145 million in support of pediatric cancer research.
FEATURED GRANT RECIPIENT
Our overall hypothesis is that in high risk B-ALL, combination treatment using a CK2 inhibitor, CX-4945, and mTOR inhibitor, rapamycin will achieve superior inhibition of the mTOR pathway and enhance cytotoxicity. Using two agents that target same signaling pathway via different mechanisms will ensure effective inhibition of a particular pathway resulting in strong therapeutic effect, and also allow to use lower doses of each drug and reduce their off target effects.
Discovery Is The Reason To Hope
Hyundai Hope On Wheels supports the finest minds in pediatric cancer research. These doctors and research scientists are the human faces of hope – to affected children and their families. Hyundai Hope On Wheels supports translational research (working directly with child cancer patients), research on low-survival cancers, research in an institution’s core pursuit and research that explores the underlying biology of childhood cancer. Grant winners are selected by a rigorous scientific review panel of physicians.